loading
전일 마감가:
$1.93
열려 있는:
$1.93
하루 거래량:
11,696
Relative Volume:
0.10
시가총액:
$5.00M
수익:
$102.80K
순이익/손실:
$-5.32M
주가수익비율:
-0.4947
EPS:
-3.8
순현금흐름:
$-5.45M
1주 성능:
-3.58%
1개월 성능:
-13.66%
6개월 성능:
-41.55%
1년 성능:
-56.83%
1일 변동 폭
Value
$1.85
$1.9648
1주일 범위
Value
$1.85
$2.10
52주 변동 폭
Value
$1.69
$6.90

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Name
명칭
Creative Medical Technology Holdings Inc
Name
전화
480-399-2822
Name
주소
211 E. OSBORN RD., PHOENIX
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
CELZ's Discussions on Twitter

CELZ을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CELZ
Creative Medical Technology Holdings Inc
1.8949 5.00M 102.80K -5.32M -5.45M -3.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.43 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
593.34 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
605.72 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.53 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
247.25 24.89B 3.81B -644.79M -669.77M -6.24

Creative Medical Technology Holdings Inc 주식(CELZ)의 최신 뉴스

pulisher
Apr 22, 2025

Creative Foam buys medical supplier AccuMed from Lear - Plastics News

Apr 22, 2025
pulisher
Apr 22, 2025

Venus Shines Again, ENZ To Be Delisted, SLP, CERT On Watch - RTTNews

Apr 22, 2025
pulisher
Apr 22, 2025

Head-To-Head Contrast: Atara Biotherapeutics (NASDAQ:ATRA) and Creative Medical Technology (NASDAQ:CELZ) - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Exosomes Drug Market Projected To Witness Substantial Growth, - openPR.com

Apr 21, 2025
pulisher
Apr 18, 2025

Mergers & Acquisitions Tracker - Plastics News

Apr 18, 2025
pulisher
Apr 14, 2025

Longevity Health to combine with 20/20 BioLabs in all-stock deal (XAGE:NASDAQ) - Seeking Alpha

Apr 14, 2025
pulisher
Apr 10, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Exosomes Market Detailed In New Research Report 2025 | Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC - newstrail.com

Apr 10, 2025
pulisher
Apr 09, 2025

CELZ stock touches 52-week low at $1.9 amid market challenges - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

CELZ stock touches 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 04, 2025

Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN

Apr 04, 2025
pulisher
Mar 31, 2025

Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews

Mar 31, 2025
pulisher
Mar 30, 2025

Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World

Mar 30, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times

Mar 20, 2025
pulisher
Mar 20, 2025

FDA Green Light: Breakthrough Cell Therapy Shows Promise in Chronic Back Pain Treatment - Stock Titan

Mar 20, 2025
pulisher
Mar 19, 2025

Nanoparticle Drug Delivery Market Growth, Generated - openPR.com

Mar 19, 2025
pulisher
Mar 18, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 16, 2025

Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo

Mar 16, 2025
pulisher
Mar 16, 2025

When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Delaware Court Just Changed the Game for Big Business - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Trump Tariffs in Chaos: Markets React - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Breaking: Trump Trade War Exposes Hidden Dangers - GeeksULTD

Mar 16, 2025
pulisher
Mar 14, 2025

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC 10-K Report - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners - The Malaysian Reserve

Mar 13, 2025
pulisher
Mar 13, 2025

Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR

Mar 13, 2025
pulisher
Mar 10, 2025

Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi - EIN News

Mar 10, 2025
pulisher
Mar 07, 2025

Creative Medical Technology secures $3.7 million through warrants By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Where are the Opportunities in (CELZ) - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology secures $3.7 million through warrants - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross - EIN News

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Heritage Distilling Co. Announces Recent Achievements and Key Milestones for Salute Series Line of Premium Whiskeys - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements For Exercise Of Warrants For $3.7 Million Gross Proceeds - MENAFN.COM

Mar 06, 2025
pulisher
Mar 06, 2025

Can This $3.7M Cash Injection Fuel Creative Medical's Next Growth Phase? - StockTitan

Mar 06, 2025

Creative Medical Technology Holdings Inc (CELZ) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Creative Medical Technology Holdings Inc 주식 (CELZ) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Finger Michael H.
Director
Feb 18 '25
Sale
5.00
750
3,750
1,101
$20.39
price down icon 0.63%
$68.60
price down icon 0.25%
$32.01
price down icon 0.09%
$34.64
price down icon 7.28%
$114.80
price down icon 4.57%
biotechnology ONC
$248.25
price down icon 2.59%
자본화:     |  볼륨(24시간):